Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8889743
Inhibition of filovirus entry into cells and uses thereof
granted -
US 8883729
Nanolipoprotein particles and related compositions, methods and systems
granted -
US 8883174
Compositions for stimulation of mammalian innate immune resistance to pathogens
granted -
US 8883841
Oncogenic ras-specific cytotoxic compound and methods of use thereof
granted -
US 8883154
Antibody-mediated modulation of allergy
granted -
US 8877797
Methods for treating Parkinson's disease using pro-neurogenic compounds
granted -
US 8877188
Detection and treatment of non-dermal fibrosis
granted -
US 8877215
Compounds with modifying activity enhanced under hypoxic conditions
granted -
US 8871794
Small-molecule agonists for type-2 orexin receptor
granted -
US 8865187
Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
granted -
US 8865199
Biomatrix composition and methods of biomatrix seeding
granted -
US 8859727
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
granted -
US 8846006
MRI markers, delivery and extraction systems, and methods of manufacture and use thereof
granted -
US 8846859
Compositions and methods of use of targeting peptides against placenta and adipose tissues
granted -
US 8841257
Inhibitors of STAT3 and uses thereof
granted -
US 8841273
Methods and compositions for anti-EGFR treatment
granted -
US 8834938
Use of arsenic for cancer therapy protection
granted -
US 8834871
Immunoglobulin molecules with improved characteristics
granted -
US 8835493
Oligo-benzamide compounds for use in treating cancers
granted -
US 8821899
Method and process for the production of multi-coated recognitive and releasing systems
granted -
US 8815212
Nanocarriers for imaging and therapy applications
granted -
US 8802656
Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same
granted -
US 8802733
Aldehyde dehydrogenase inhibitors as novel depigmenting agents
granted -
US 8802633
Autophagy-inducing peptide analogs
granted